{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:22:07Z","timestamp":1771953727568,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"33","license":[{"start":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T00:00:00Z","timestamp":1415577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T00:00:00Z","timestamp":1415577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2015,8,13]]},"DOI":"10.1038\/onc.2014.368","type":"journal-article","created":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T11:38:30Z","timestamp":1415619510000},"page":"4379-4390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["RETRACTED ARTICLE: FOXC2 promotes colorectal cancer metastasis by directly targeting MET"],"prefix":"10.1038","volume":"34","author":[{"given":"Y-M","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H-L","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y-P","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C-M","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-X","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T-T","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S-Y","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M-R","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X-W","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W-T","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y-Q","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,10]]},"reference":[{"key":"BFonc2014368_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin 2011; 61: 69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"BFonc2014368_CR2","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/S0140-6736(13)60978-2","volume":"381","author":"E Van Cutsem","year":"2013","unstructured":"Van Cutsem E, Grothey A . Regorafenib for metastatic colorectal cancer\u2014authors' reply. Lancet 2013; 381: 1538\u20131539.","journal-title":"Lancet"},{"key":"BFonc2014368_CR3","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.ejca.2007.03.021","volume":"43","author":"MJ Duffy","year":"2007","unstructured":"Duffy MJ, van Dalen A, Haglund C, Hansson L, Holinski-Feder E, Klapdor R et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 2007; 43: 1348\u20131360.","journal-title":"Eur J Cancer"},{"key":"BFonc2014368_CR4","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1056\/NEJMra0804588","volume":"361","author":"SD Markowitz","year":"2009","unstructured":"Markowitz SD, Bertagnolli MM . Molecular origins of cancer: molecular basis of colorectal cancer. New Engl J Med 2009; 361: 2449\u20132460.","journal-title":"New Engl J Med"},{"key":"BFonc2014368_CR5","doi-asserted-by":"publisher","first-page":"23791","DOI":"10.1074\/jbc.M800190200","volume":"283","author":"H Hayashi","year":"2008","unstructured":"Hayashi H, Sano H, Seo S, Kume T . The Foxc2 transcription factor regulates angiogenesis via induction of integrin beta3 expression. J Biol Chem 2008; 283: 23791\u201323800.","journal-title":"J Biol Chem"},{"key":"BFonc2014368_CR6","doi-asserted-by":"publisher","first-page":"204593","DOI":"10.1155\/2012\/204593","volume":"2012","author":"T Kume","year":"2012","unstructured":"Kume T . The role of FoxC2 transcription factor in tumor angiogenesis. J Oncol 2012; 2012: 204593.","journal-title":"J Oncol"},{"key":"BFonc2014368_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.bbrc.2010.01.015","volume":"392","author":"H Sano","year":"2010","unstructured":"Sano H, Leboeuf JP, Novitskiy SV, Seo S, Zaja-Milatovic S, Dikov MM et al. The Foxc2 transcription factor regulates tumor angiogenesis. Biochem Biophys Res Commun 2010; 392: 201\u2013206.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc2014368_CR8","doi-asserted-by":"publisher","first-page":"10069","DOI":"10.1073\/pnas.0703900104","volume":"104","author":"SA Mani","year":"2007","unstructured":"Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, Miura N et al. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci USA 2007; 104: 10069\u201310074.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014368_CR9","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1158\/0008-5472.CAN-12-2962","volume":"73","author":"BG Hollier","year":"2013","unstructured":"Hollier BG, Tinnirello AA, Werden SJ, Evans KW, Taube JH, Sarkar TR et al. FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer. Cancer Res 2013; 73: 1981\u20131992.","journal-title":"Cancer Res"},{"key":"BFonc2014368_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1245\/s10434-010-1274-y","volume":"18","author":"N Nishida","year":"2011","unstructured":"Nishida N, Mimori K, Yokobori T, Sudo T, Tanaka F, Shibata K et al. FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma. Ann Surg Oncol 2011; 18: 535\u2013542.","journal-title":"Ann Surg Oncol"},{"key":"BFonc2014368_CR11","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/his.12132","volume":"62","author":"JL Zhu","year":"2013","unstructured":"Zhu JL, Song YX, Wang ZN, Gao P, Wang MX, Dong YL et al. The clinical significance of mesenchyme forkhead 1 (FoxC2) in gastric carcinoma. Histopathology 2013; 62: 1038\u20131048.","journal-title":"Histopathology"},{"key":"BFonc2014368_CR12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cllc.2011.11.005","volume":"13","author":"W Jiang","year":"2012","unstructured":"Jiang W, Pang XG, Wang Q, Shen YX, Chen XK, Xi JJ . Prognostic role of Twist, Slug, and Foxc2 expression in stage I non-small-cell lung cancer after curative resection. Clin Lung Cancer 2012; 13: 280\u2013287.","journal-title":"Clin Lung Cancer"},{"key":"BFonc2014368_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/onc.2012.74","volume":"32","author":"YH Yu","year":"2013","unstructured":"Yu YH, Chen HA, Chen PS, Cheng YJ, Hsu WH, Chang YW et al. MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol. Oncogene 2013; 32: 431\u2013443.","journal-title":"Oncogene"},{"key":"BFonc2014368_CR14","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1158\/1541-7786.MCR-10-0004","volume":"8","author":"F Mortazavi","year":"2010","unstructured":"Mortazavi F, An J, Dubinett S, Rettig M . p120-catenin is transcriptionally downregulated by FOXC2 in non-small cell lung cancer cells. Mol Cancer Res 2010; 8: 762\u2013774.","journal-title":"Mol Cancer Res"},{"key":"BFonc2014368_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nrc2622","volume":"9","author":"DX Nguyen","year":"2009","unstructured":"Nguyen DX, Bos PD, Massague J . Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009; 9: 274\u2013284.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2014368_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan S, Weinberg RA . Tumor metastasis: molecular insights and evolving paradigms. Cell 2011; 147: 275\u2013292.","journal-title":"Cell"},{"key":"BFonc2014368_CR17","doi-asserted-by":"publisher","first-page":"10167","DOI":"10.1073\/pnas.0802486105","volume":"105","author":"Y Xue","year":"2008","unstructured":"Xue Y, Cao R, Nilsson D, Chen S, Westergren R, Hedlund EM et al. FOXC2 controls Ang-2 expression and modulates angiogenesis, vascular patterning, remodeling, and functions in adipose tissue. Proc Natl Acad Sci USA 2008; 105: 10167\u201310172.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014368_CR18","first-page":"147","volume":"1","author":"MF Di Renzo","year":"1995","unstructured":"Di Renzo MF, Olivero M, Giacomini A, Porte H, Chastre E, Mirossay L et al. Overexpression and amplification of the met\/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1995; 1: 147\u2013154.","journal-title":"Clin Cancer Res"},{"key":"BFonc2014368_CR19","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrm1261","volume":"4","author":"C Birchmeier","year":"2003","unstructured":"Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF . Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003; 4: 915\u2013925.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2014368_CR20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11912-007-0005-4","volume":"9","author":"M Sattler","year":"2007","unstructured":"Sattler M, Salgia R . c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy. Curr Oncol Rep 2007; 9: 102\u2013108.","journal-title":"Curr Oncol Rep"},{"key":"BFonc2014368_CR21","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1096\/fj.06-5947rev","volume":"20","author":"M Mazzone","year":"2006","unstructured":"Mazzone M, Comoglio PM . The Met pathway: master switch and drug target in cancer progression. FASEB J 2006; 20: 1611\u20131621.","journal-title":"FASEB J"},{"key":"BFonc2014368_CR22","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1126\/science.1846706","volume":"251","author":"DP Bottaro","year":"1991","unstructured":"Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251: 802\u2013804.","journal-title":"Science"},{"key":"BFonc2014368_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1083\/jcb.200701086","volume":"177","author":"J Chmielowiec","year":"2007","unstructured":"Chmielowiec J, Borowiak M, Morkel M, Stradal T, Munz B, Werner S et al. c-Met is essential for wound healing in the skin. J Cell Biol 2007; 177: 151\u2013162.","journal-title":"J Cell Biol"},{"key":"BFonc2014368_CR24","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1172\/JCI0215418","volume":"109","author":"A Danilkovitch-Miagkova","year":"2002","unstructured":"Danilkovitch-Miagkova A, Zbar B . Dysregulation of Met receptor tyrosine kinase activity in invasive tumors. J Clin Invest 2002; 109: 863\u2013867.","journal-title":"J Clin Invest"},{"key":"BFonc2014368_CR25","first-page":"4807","volume":"29","author":"AT De Oliveira","year":"2009","unstructured":"De Oliveira AT, Matos D, Logullo AF, DA Silva SR, Neto RA, Filho AL et al. MET Is highly expressed in advanced stages of colorectal cancer and indicates worse prognosis and mortality. Anticancer Res 2009; 29: 4807\u20134811.","journal-title":"Anticancer Res"},{"key":"BFonc2014368_CR26","first-page":"1480","volume":"9","author":"H Takeuchi","year":"2003","unstructured":"Takeuchi H, Bilchik A, Saha S, Turner R, Wiese D, Tanaka M et al. c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases. Clin Cancer Res 2003; 9: 1480\u20131488.","journal-title":"Clin Cancer Res"},{"key":"BFonc2014368_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.canlet.2006.07.007","volume":"248","author":"US Kammula","year":"2007","unstructured":"Kammula US, Kuntz EJ, Francone TD, Zeng Z, Shia J, Landmann RG et al. Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome. Cancer Lett 2007; 248: 219\u2013228.","journal-title":"Cancer Lett"},{"key":"BFonc2014368_CR28","first-page":"181","volume":"7","author":"C Liu","year":"1992","unstructured":"Liu C, Park M, Tsao MS . Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas. Oncogene 1992; 7: 181\u2013185.","journal-title":"Oncogene"},{"key":"BFonc2014368_CR29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.canlet.2008.02.049","volume":"265","author":"ZS Zeng","year":"2008","unstructured":"Zeng ZS, Weiser MR, Kuntz E, Chen CT, Khan SA, Forslund A et al. c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases. Cancer Lett 2008; 265: 258\u2013269.","journal-title":"Cancer Lett"},{"key":"BFonc2014368_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1535-6108(03)00085-0","volume":"3","author":"S Pennacchietti","year":"2003","unstructured":"Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM . Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer cell 2003; 3: 347\u2013361.","journal-title":"Cancer cell"},{"key":"BFonc2014368_CR31","first-page":"5126","volume":"62","author":"EM Boon","year":"2002","unstructured":"Boon EM, van der Neut R, van de Wetering M, Clevers H, Pals ST . Wnt signaling regulates expression of the receptor tyrosine kinase met in colorectal cancer. Cancer Res 2002; 62: 5126\u20135128.","journal-title":"Cancer Res"},{"key":"BFonc2014368_CR32","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/sj.onc.1209859","volume":"26","author":"A Rasola","year":"2007","unstructured":"Rasola A, Fassetta M, De Bacco F, D'Alessandro L, Gramaglia D, Di Renzo MF et al. A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth. Oncogene 2007; 26: 1078\u20131087.","journal-title":"Oncogene"},{"key":"BFonc2014368_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-3-540-46091-6_7","volume":"176","author":"U Stein","year":"2007","unstructured":"Stein U, Clinical Schlag PM . biological, and molecular aspects of metastasis in colorectal cancer. Recent Results Cancer Res 2007; 176: 61\u201380.","journal-title":"Recent Results Cancer Res"},{"key":"BFonc2014368_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nm.1889","volume":"15","author":"U Stein","year":"2009","unstructured":"Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 2009; 15: 59\u201367.","journal-title":"Nat Med"},{"key":"BFonc2014368_CR35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0378-1119(98)00264-9","volume":"215","author":"Y Liu","year":"1998","unstructured":"Liu Y . The human hepatocyte growth factor receptor gene: complete structural organization and promoter characterization. Gene 1998; 215: 159\u2013169.","journal-title":"Gene"},{"key":"BFonc2014368_CR36","first-page":"1057","volume":"24","author":"H Liang","year":"2004","unstructured":"Liang H, O'Reilly S, Liu Y, Abounader R, Laterra J, Maher VM et al. Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity. Int J Oncol 2004; 24: 1057\u20131067.","journal-title":"Int J Oncol"},{"key":"BFonc2014368_CR37","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1517\/13543784.17.7.997","volume":"17","author":"X Liu","year":"2008","unstructured":"Liu X, Yao W, Newton RC, Scherle PA . Targeting the c-MET signaling pathway for cancer therapy. Expert Opin Investig Drugs 2008; 17: 997\u20131011.","journal-title":"Expert Opin Investig Drugs"},{"key":"BFonc2014368_CR38","doi-asserted-by":"publisher","first-page":"e64709","DOI":"10.1371\/journal.pone.0064709","volume":"8","author":"SH Zhang","year":"2013","unstructured":"Zhang SH, Wang CJ, Shi L, Li XH, Zhou J, Song LB et al. High Expression of FLOT1 is associated with progression and poor prognosis in hepatocellular carcinoma. PLoS ONE 2013; 8: e64709.","journal-title":"PLoS ONE"},{"key":"BFonc2014368_CR39","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.bone.2011.05.012","volume":"49","author":"SJ Park","year":"2011","unstructured":"Park SJ, Gadi J, Cho KW, Kim KJ, Kim SH, Jung HS et al. The forkhead transcription factor Foxc2 promotes osteoblastogenesis via up-regulation of integrin beta1 expression. Bone 2011; 49: 428\u2013438.","journal-title":"Bone"},{"key":"BFonc2014368_CR40","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.1158\/0008-5472.CAN-06-0094","volume":"66","author":"LB Song","year":"2006","unstructured":"Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 2006; 66: 6225\u20136232.","journal-title":"Cancer Res"},{"key":"BFonc2014368_CR41","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1158\/1078-0432.CCR-10-2533","volume":"17","author":"WT Liao","year":"2011","unstructured":"Liao WT, Jiang D, Yuan J, Cui YM, Shi XW, Chen CM et al. HOXB7 as a prognostic factor and mediator of colorectal cancer progression. Clin Cancer Res 2011; 17: 3569\u20133578.","journal-title":"Clin Cancer Res"},{"key":"BFonc2014368_CR42","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1158\/2159-8290.CD-11-0239","volume":"2","author":"T Shibue","year":"2012","unstructured":"Shibue T, Brooks MW, Inan MF, Reinhardt F, Weinberg RA . The outgrowth of micrometastases is enabled by the formation of filopodium-like protrusions. Cancer Discov 2012; 2: 706\u2013721.","journal-title":"Cancer Discov"},{"key":"BFonc2014368_CR43","first-page":"484","volume":"10","author":"W Tseng","year":"2007","unstructured":"Tseng W, Leong X, Engleman E . Orthotopic mouse model of colorectal cancer. J Vis Exp 2007; 10: 484.","journal-title":"J Vis Exp"}],"updated-by":[{"DOI":"10.1038\/s41388-022-02287-w","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"record-id":"36399"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2014368.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2014368","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2014368.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T01:07:12Z","timestamp":1650071232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2014368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,10]]},"references-count":43,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2015,8,13]]}},"alternative-id":["BFonc2014368"],"URL":"https:\/\/doi.org\/10.1038\/onc.2014.368","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,10]]},"assertion":[{"value":"24 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41388-022-02287-w","URL":"https:\/\/doi.org\/10.1038\/s41388-022-02287-w","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}